Robert L. Myers, Chief Financial Officer at BioDrain Medical, Inc. (BIOR), bought 6,250 shares at $0.08 ($500) on 2013-03-08, disclosed to the SEC on 2013-03-11.
Open-market purchase of $500 BIOR by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SKLN | BUY | 2014-09-15 | $650 | — | Filing → |
| SKLN | BUY | 2014-08-22 | $750 | — | Filing → |